MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AURA — Aura Biosciences, Inc. Common Stock
NasdaqAura Biosciences, Inc. Common Stock
$6.09
+0.05(+0.83%)
- O
- 6.11
- H
- 6.15
- L
- 5.97
- V
- 2.1M
⏱️ End-of-day dataAs of Oct 2, 2026
AURA — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $84.79M | $59.52M | $47.55M | $10.74M | $38.23M | $31.69M |
| Other Short Term Investments | $29.94M | $84.73M | $11.43M | $69.94M | $89.77M | $11.94M |
| Prepaid Assets | $2.71M | $4.32M | $5.67M | $4.03M | $4.75M | $7.70M |
| Other Current Assets | $1.06M | $1.18M | $2.58M | $2.62M | $1.77M | $1.83M |
| Total Current Assets | $11.85M | $14.97M | $17.01M | $18.40M | $13.45M | $16.06M |
| Properties | $24.44M | $24.80M | $25.09M | $25.43M | $25.68M | $25.84M |
| Construction In Progress | 307,000.00 | 228,000.00 | 143,000.00 | 151,000.00 | 245,000.00 | 272,000.00 |
| Leases | 471,000.00 | 471,000.00 | 471,000.00 | 471,000.00 | 471,000.00 | 471,000.00 |
| Accumulated Depreciation | $-7.33M | $-7.05M | $-6.84M | $-6.56M | $-6.28M | $-5.99M |
| Other Non Current Assets | $1.28M | $1.24M | $1.04M | 953,000.00 | 768,000.00 | $1.29M |
| Total Non Current Assets | $19.17M | $19.69M | $19.90M | $20.44M | $20.88M | $21.88M |
| Total Assets | $13.77M | $16.94M | $19.00M | $20.44M | $15.54M | $18.25M |
| Accounts Payable | $2.57M | $1.55M | $1.89M | $1.29M | $2.01M | $2.30M |
| Accrued Expenses | $7.90M | $7.34M | $7.46M | $5.75M | $3.81M | $3.39M |
| Short Term Debt | $3.27M | $3.24M | $3.22M | $3.20M | $3.17M | $3.15M |
| Pensions | $2.59M | $6.00M | $6.10M | $4.39M | $2.76M | $5.46M |
| Other Current Liabilities | 378,000.00 | 242,000.00 | 152,000.00 | 227,000.00 | 412,000.00 | 618,000.00 |
| Total Current Liabilities | $16.71M | $18.38M | $18.82M | $14.85M | $12.16M | $14.91M |
| Long Term Debt | $13.72M | $14.13M | $14.53M | $14.92M | $15.27M | $15.62M |
| Total Non Current Liabilities | $13.72M | $14.13M | $14.53M | $14.92M | $15.27M | $15.62M |
| Total Liabilities | $30.43M | $32.52M | $33.36M | $29.77M | $27.43M | $30.53M |
| Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | $-51.41M | $-48.04M | $-45.49M | $-42.87M | $-40.17M | $-37.42M |
| Other Shareholders Equity | -207,000.00 | -102,000.00 | 69,000.00 | 25,000.00 | 105,000.00 | 263,000.00 |
| Total Shareholders Equity | $10.72M | $13.69M | $15.67M | $17.46M | $12.80M | $15.20M |
| Additional Paid In Capital | $62.16M | $61.74M | $61.15M | $60.33M | $52.96M | $52.59M |
| Restricted Cash | N/A | N/A | N/A | N/A | N/A | 0.00 |